Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

le McGurnaghan, S., Blackbourn, L. A. K., Mocevic, E., Haagen Panton, U., McCrimmon, R. J., Sattar, N., Wild, S., Colhoun, H. M.
Foilsithe in Diabet Med (2018)

Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes

le Fan, X., Ding, Y., Brown, S., Zhou, L., Shaw, M., Vella, M. C., Cheng, H., McNay, E. C., Sherwin, R. S., McCrimmon, R. J.
Foilsithe 2009

Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) proje...

le de Galan, B. E., McCrimmon, R. J., Ibberson, M., Heller, S. R., Choudhary, P., Pouwer, F., Speight, J., Carlton, J., Pieber, T. R., Rosilio, M., Tack, C. J., Müllenborn, M.
Foilsithe in Diabet Med (2020)

Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour

le Beall, C., Hamilton, D. L., Gallagher, J., Logie, L., Wright, K., Soutar, M. P., Dadak, S., Ashford, F. B., Haythorne, E., Du, Q., Jovanović, A., McCrimmon, R. J., Ashford, M. L. J.
Foilsithe 2012